Concepedia

Publication | Open Access

Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the <scp>A</scp>ustralian compassionate access cohort

31

Citations

39

References

2015

Year

Abstract

Eculizumab has been an effective therapy for aHUS in this cohort, including when other therapies have failed.

References

YearCitations

Page 1